Clinical Trial Update: Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety, blood levels, and exploratory effects of AUT00201 in patients with progressive myoclonus epilepsy; results completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Myoclonus Epilepsy

Drugs mentioned

• AUT00201

Snippet

Sponsor: Autifony Therapeutics Limited | Conditions: Myoclonus Epilepsies, Progressive | Phase 1 | Status: COMPLETED | Results posted: 2025-03-25